ArticleActa neurologica Belgica2026
Spino-cerebellar Ataxia 31 presenting as a demyelinating disease: a case report.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinocerebellar ataxia (SCA) is a group of inherited disorders that encompasses different types and presentations. One of its types, SCA31, is a rare ataxia that has a wide spectrum of presentations. Therefore, it may be mistakenly diagnosed with another neurological disorder. Here we describe a 52-year-old woman with progressive imbalance and lower limb weakness who was initially diagnosed with multiple sclerosis (MS) based on periventricular MRI lesions and cerebrospinal fluid oligoclonal bands. She received interferon-beta for four years without improvement. After mistreatment for years, she was reassessed and, due to a strong family history of similar ataxic symptoms, was prompted to undergo genetic testing, which confirmed SCA31. This case highlights the diagnostic challenges associated with SCA31 that can mimic MS because of overlapping clinical and radiological features, potentially leading to misdiagnosis and inappropriate treatment. Therefore, clinicians should exercise caution and consider alternative diagnoses, particularly in the presence of poor response to immunotherapy, a progressive disease course, and a positive family history, all of which may indicate an inherited ataxia.
Indexed as
Identifiers
41240275What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.